Podcast
MSL Talk: Tom Caravela, Mitchell D’Rozario
Finding Success as a Rare Diseases MSL
Summary
In this episode, Giovanni Passiatore delves into the complexities of working in the rare diseases arena as an MSL. Giovanni shares his extensive background and provides insights into the unique challenges faced in this field, including strategies for effective territory coverage and engaging with key opinion leaders. He highlights the critical role of patient identification and the emerging importance of patient diagnosis liaisons. Giovanni offers essential advice for aspiring MSLs, emphasizing the significance of humility, relationship-building, and business acumen. The episode wraps up with a focus on the resilience required for success in the MSL role and appreciation for the audience's engagement.
My guest today is Giovanni Passiatore, Head of US MSLs at Chiesi Rare Disease and he shares insights on how to find success as a Rare Diseases MSL
Giovanni discusses…
👉 What the industry considers “Rare Diseases” as a category
👉 Challenges Rare Diseases Medical Affairs/MSL teams face
👉 How the medical affairs strategy differs for a Rare Diseases company
👉 How metrics and KPIs may differ for Rare Disease MSLs
👉 Recommendations for Rare Disease MSLs to find success and become high performers in their territory
👉 What he looks for when hiring Rare Diseases MSLs
rare diseases MSL, medical science liaison challenges, key opinion leaders engagement, patient diagnosis liaisons, rare disease territory coverage
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Mitchell D’Rozario
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
iNIZIO
Clinical Educator Oncology Program Improves Adherence by 29%
Article
Forbes Books Press Release Official